Ptc Therapeutics, Inc. · NASDAQ:PTCT

Schmertzler Michael sold 20,000 Ptc Therapeutics, Inc. shares (Form 4)

Traded Sep 16 to Sep 17, 2026 · Filed Sep 18, 2026

From Sep 16 to Sep 17, 2026, Schmertzler Michael (Director) sold 20,000 Ptc Therapeutics, Inc. shares at an average US$67.49 for US$1.35M under a trading plan, leaving 1,296,594 shares. Filed Sep 18, 2026 (Form 4).

Sold
20,000 shares
Price
US$67.49 average (US$66.58 to US$68.45)
Value
US$1.35M
Holding after
1,296,594 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 16, 2026Common StockSale2,994US$66.581,313,600Indirect
Sep 16, 2026Common StockSale7,006US$67.351,306,594Indirect
Sep 17, 2026Common StockSale9,624US$67.831,296,970Indirect
Sep 17, 2026Common StockSale376US$68.451,296,594Indirect

Source

View original at SEC

Related